Advertisement
Advertisement
U.S. markets close in 1 hour 5 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Relief Therapeutics Holding AG (RLFTF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0310-0.0020 (-6.06%)
As of 02:35PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0330
Open0.0320
BidN/A x N/A
AskN/A x N/A
Day's Range0.0300 - 0.0330
52 Week Range0.0210 - 0.1400
Volume589,088
Avg. Volume927,364
Market Cap129.978M
Beta (5Y Monthly)-14.82
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for RLFTF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • RELIEF THERAPEUTICS HOLDING AG
    VIR: What does Argus have to say about VIR?VIR BIOTECHNOLOGY INC has an Investment Rating of HOLD; a target price of $29.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
Advertisement
Advertisement